Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03033914
Brief Title: A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

First Submitted : January 25, 2017
First Submitted that Met QC Criteria : January 25, 2017
First Posted : January 27, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : April 8, 2019
Last Update Posted : April 10, 2019